26-WEEK RESULTS Superior weight reduction with RYBELSUS 14 mg and 7 mg vs Januvia 1,2 RYBELSUS is not indicated for weight loss
Semaglutide, available as Ozempic for type 2 diabetes and Wegovy for chronic weight management, and tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, are prominent examples of FDA-approved GLP-1 receptor agonists (Kommu S et al., 2025
These results are best achieved when injections are combined with customized dietary strategies, physical activity, and supplement support
With no adverse reactions or unwanted side effects, I am more than satisfied with my choice
Plasma insulin levels were not affected by metformin during fasting, but were comparably augmented following intraduodenal glucose infusion on all the three metformin study days
Oral semaglutide at higher doses studied for weight management produced very similar average weight loss over about 64 weeks